跳至主要内容
临床试验/KCT0005999
KCT0005999招募中未知

MR-target Biopsy vs. TRUS-biopsy in Men with Suspicious Prostate Cancer: A paired Cohort blinded Study

Asan Medical Center0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
50(Year) 至 80(Year)(—)
性别
Male

入选标准

  • 1. Men undergoing a first-time prostate biopsy to rule out cancer
  • 2. Serum PSA =3ng/mL, =20ng/mL
  • 3. Age=50 years, =80 years
  • 4. Clinical stage =T2c
  • 5. Patients must be able to provide written informed consent.

排除标准

  • 1. Patients has any prior needle biopsy of the prostate
  • 2. Patients has a prior history of prostate cancer
  • 3. Patients has a prior history of pelvic radiation therapy or androgen deprivation therapy
  • 4. Patients has a prior history of BPH operation
  • 5. Patient with uncorrectable coagulopathies
  • 6. Unable to tolerate a TRUS guided biopsy.
  • 7. Patients had 5-alpha reductase inhibitor in the past six months.
  • 8. The patient has had a urinary tract infection or acute prostatitis in the last three months.
  • 9. Any contraindication to MRI (severe claustrophobia, pacemaker, MRI-incompatible prosthesis, eGFR =50mls/min)

研究者

相似试验